Data / Form D filings / Phagos, Inc.
Phagos, Inc.: Form D filings
Phagos, Inc., a biotechnology company in Ivry-Sur-Seine, France, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on November 18, 2024, reports an offering of $7.6 million with nothing sold yet to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 rue Jean-Jacques Rousseau, F2-112-5, Ivry-Sur-Seine, France, 94200
- Phone
- 33 7 82 51 34 53
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1937230
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | New notice | $7,624,421 | $0 | $7,624,421 | 13 | Oct 29, 2024 | sec.gov |
| Sep 15, 2022 | New notice | $1,451,725 | $1,451,725 | 7 | Jul 6, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Kniaz | Director | |
| Xin Ma | Director | |
| Geoffroy Dubus | Director | |
| Alexandros Pantalis | Executive Officer, Director | |
| Adele James | Director |
Every Form D from the week of Nov 18, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Phagos, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.